on 13 Oct 2020
Last Applicant/ Owned by
1801 AUGUSTINE CUT-O
WILMINGTON
E
19803
Serial Number
88682860 filed on 06th Nov 2019
Registration Number
6173000 registered on 13th Oct 2020
Correspondent Address
Michael J. Leonard OX ROTHSCHIL LLP
Filing Basis
1. intent to use
Disclaimer
NO DATA
Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; Read More
Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
11th 000101
11th 000101
Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
11th 000101
11th 000101
No 88682860
No Service Mark
No 114353.00103
Yes
No
No
Yes
No
No
No
No
26.05.13 -
Two Triangles
26.05.16 -
Triangles touching or intersecting
26.05.21 -
Triangles that are completely or partially shaded
| Status Date | Action Taken |
|---|---|
| 01st May 2024 | AUTOMATIC UPATE O ASSIGNMENT O OWNERSHIP |
| 24th Apr 2024 | ASSIGNMENT O OWNERSHIP NOT UPATE AUTOMATICALLY |
| 13th Oct 2020 | REGISTERE-PRINCIPAL REGISTER |
| 28th Jul 2020 | OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE |
| 28th Jul 2020 | PUBLISHE OR OPPOSITION |
| 08th Jul 2020 | NOTIICATION O NOTICE O PUBLICATION E-MAILE |
| 22nd Jun 2020 | APPROVE OR PUB - PRINCIPAL REGISTER |
| 22nd Jun 2020 | CORRESPONENCE RECEIVE IN LAW OICE |
| 22nd Jun 2020 | TEAS/EMAIL CORRESPONENCE ENTERE |
| 18th Jun 2020 | ASSIGNE TO LIE |
